November 17, 2016 - By Vivian Park · 0 Comments
Sunshine Heart Inc (NASDAQ:SSH) institutional sentiment is 0.54 in 2016 Q2. Its the same as in 2016Q1. The ratio is neither negative nor positive, as only 7 investment managers increased or started new holdings, while 13 sold and decreased their stakes in Sunshine Heart Inc. The investment managers in our partner’s database now hold: 1.15 million shares, down from 1.25 million shares in 2016Q1. Also, the number of investment managers holding Sunshine Heart Inc in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 4 Reduced: 9 Increased: 4 New Position: 3.
About 52,089 shares traded hands. Sunshine Heart Inc (NASDAQ:SSH) has declined 75.68% since April 15, 2016 and is downtrending. It has underperformed by 80.30% the S&P500.
According to Zacks Investment Research, “Sunshine Heart, Inc. is a medical device company engaged in the commercialization of the C-Pulse Heart Assist System, an implantable, non-blood contacting, heart assist therapy for the treatment of moderate to severe heart failure. Sunshine Heart, Inc. is headquartered in Minneapolis.”
Benchmark Capital Advisors holds 0.04% of its portfolio in Sunshine Heart Inc for 98,500 shares. Bank Of America Corp De owns 2,943 shares or 0% of their US portfolio. Moreover, Blackrock Fund Advisors has 0% invested in the company for 21,729 shares. The New York-based Citigroup Inc has invested 0% in the stock. Creative Planning, a Kansas-based fund reported 2,000 shares.#img1#
Ratings analysis reveals 33% of Sunshine Heart’s analysts are positive. Out of 3 Wall Street analysts rating Sunshine Heart, 1 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $9 while the high is $10. The stock’s average target of $9 is 4984.75% above today’s ($0.177) share price. SSH was included in 6 notes of analysts from August 5, 2015. The stock of Sunshine Heart Inc (NASDAQ:SSH) has “Hold” rating given on Friday, September 4 by Zacks. The stock of Sunshine Heart Inc (NASDAQ:SSH) has “Outperform” rating given on Tuesday, November 10 by Oppenheimer. The rating was maintained by Canaccord Genuity on Tuesday, September 1 with “Buy”. The firm has “Outperform” rating given on Wednesday, August 5 by Oppenheimer. The company was downgraded on Saturday, August 29 by Zacks.
Sunshine Heart, Inc., incorporated on August 22, 2002, is a medical device company. The Firm operates through cardiac and coronary disease products segment. The Firm is focused on developing, manufacturing and commercializing its C-Pulse Heart Assist System (the C-Pulse System) for treatment of Class III and ambulatory Class IV heart failure.
More notable recent Sunshine Heart Inc (NASDAQ:SSH) news were published by: Seekingalpha.com which released: “Can Sunshine Heart Survive To See The Dawn?” on February 27, 2016, also Seekingalpha.com with their article: “Sunshine Heart Inc.: A Sleeping Giant” published on August 23, 2013, Tcbmag.com published: “Sunshine Heart Raises $3.8 Million” on November 02, 2016. More interesting news about Sunshine Heart Inc (NASDAQ:SSH) were released by: Seekingalpha.com and their article: “Sunshine Heart – A Speculative Biotech Play For Substantial Short-Term Gains” published on January 14, 2016 as well as Globenewswire.com‘s news article titled: “Sunshine Heart Announces Clinical Update and Product Development Strategy” with publication date: July 11, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Vivian Park